While the extent of PTEN involvement in NPC tumorigenesis is an area of current investigation, loss of PTEN function through deletion, mutation, and/or decreased expression has been found in numerous human sporadic cancers [18], [19] and in hereditary cancer syndromes [20], [21]. This evidence concerns the gene PTEN and Inherited cancer-predisposing syndrome.